Link Between Fosamax and Jaw Decay Found in New Study
A new study provides new evidence linking the bone drug Fosamax to an increased risk of jaw bone death, involving a rare condition known as osteonecrosis of the jaw.
A new study provides new evidence linking the bone drug Fosamax to an increased risk of jaw bone death, involving a rare condition known as osteonecrosis of the jaw.
Merck may face a hundreds Fosamax trials nationwide, as the federal MDL over jaw injuries is wound down over the next six months.
A federal judge has rejected an attempt by Merck to whittle down the number of Fosamax lawsuits it could end up facing in courts nationwide after settlement talks fell through.
A New Jersey jury returned a defense verdict this week in a trial over claims that the bone-strengthening drug Zometa caused a woman’s jaw bone to decay.
A New York jury has awarded $285,000 in damages to a woman who suffered jaw decay that she claimed was caused by side effects of Fosamax, a popular osteoporosis drug…
The judge presiding over all federal Fosamax lawsuits involving osteonecrosis of the jaw (ONJ) or other jaw bone injuries, has issued an order calling for plaintiffs in many of the…
A New York jury has awarded $10.45 million to a woman who filed a product liability lawsuit alleging that the bone strengthening drug Zometa caused severe jaw damage.
Women with low bone density that is not severe enough to be considered osteoporosis, should avoid medications like Fosamax, according to Consumer Reports, as the benefits provided by the treatment…
After three years, two jury trials and appeals involving a number of issues, Merck has reportedly agreed to stipulate to a damage award in the first Fosamax “bellwether” case involving…
The New Jersey judge who is presiding over the Fosamax litigation in the state has decided that the next trial date will involve a lawsuit over a femur fracture from…